Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number | Exp. Date | Activity Code(s) | Title |
|---|---|---|---|
| PAR-25-369 | November 19, 2026 | R21 | Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) |
| PAR-25-371 | November 19, 2026 | R01 | Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) |
| PAR-25-370 | November 17, 2026 | R03 | Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) |
| PAR-25-312 | January 12, 2028 | R01 | Time-Sensitive Evaluation of Policies Affecting Health Behaviors and Chronic Disease Risk (R01-Clinical Trial Not Allowed) |
| RFA-AT-25-003 | November 24, 2026 | R15 | HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) |
| RFA-AT-25-002 | May 6, 2025 | R01 | Limited Competition: Advancing the Science of Complementary and Integrative Health Approaches to Improve Maternal Health Outcomes (R01 Clinical Trial Required) |
| PAR-25-362 | January 8, 2029 | R01 | Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) |
| PA-25-301 | January 8, 2028 | R01 | NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
| PA-25-304 | January 8, 2028 | R21 | NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) |
| PA-25-305 | January 8, 2028 | R01 | NIH Research Project Grant (Parent R01 Clinical Trial Required) |
| PA-25-302 | January 8, 2028 | R03 | NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) |
| PA-25-303 | January 8, 2028 | R01 | NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) |
| PA-25-306 | January 8, 2028 | R21 | NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) |
| PA-25-307 | January 8, 2028 | R21 | NIH Exploratory/Developmental Research Project Grant (Parent R21 Basic Experimental Studies with Humans Required) |
| RFA-DA-25-077 | March 21, 2025 | R33 | HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional) |
| RFA-DA-25-078 | March 21, 2025 | R61/R33 | HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional) |
| PAR-25-311 | November 16, 2027 | UG3/UH3 | Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) |
| NOT-HD-24-045 | January 1, 2028 | Notice of Change to PAR-25-148 Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | |
| PAR-25-296 | October 20, 2027 | UG3/UH3 | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) |
| PAR-25-154 | July 17, 2026 | R03 | HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) |
BACK TO TOP